What are the potential interactions between modafinil (Provigil) and pregabalin (Lyrica)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Modafinil and Pregabalin Drug Interaction

Modafinil can potentially reduce the effectiveness of pregabalin through pharmacokinetic interactions, requiring close monitoring and possible dose adjustments when these medications are used concurrently.

Mechanism of Interaction

Modafinil is known to induce several cytochrome P450 enzymes and can affect drug transport mechanisms. According to the evidence:

  • Modafinil is listed as a drug that can interact with hormonal contraceptives through enzyme induction 1
  • Modafinil "induces and inhibits several cytochrome P450 isoenzymes and has the potential for interacting with drugs from all classes" 2
  • Modafinil acts as a dopamine transporter inhibitor and affects catecholaminergic signaling 3

While pregabalin itself is not metabolized by the liver and is primarily excreted unchanged by the kidneys, the interaction may occur through indirect mechanisms:

  • Pregabalin is used for neuropathic pain conditions and fibromyalgia 4
  • Modafinil's enzyme-inducing properties could potentially affect the pharmacodynamics of pregabalin

Clinical Implications

Potential Effects

  1. Reduced Efficacy: Modafinil may potentially reduce the effectiveness of pregabalin through its enzyme-inducing properties

  2. CNS Effects: Both medications act on the central nervous system:

    • Modafinil is a wake-promoting agent 2
    • Pregabalin is used for neuropathic pain and has sedative properties 4
    • The combination could lead to unpredictable effects on alertness and cognition
  3. Adverse Effects: The combination may increase the risk of:

    • Insomnia (common with modafinil) 2
    • Dizziness (reported with both medications) 4, 2
    • Headache (common with modafinil) 2

Risk Factors

Certain patient populations may be at higher risk when using this combination:

  • Patients with renal impairment: Pregabalin requires dose adjustment based on renal function 4
  • Elderly patients: Modafinil dose should be reduced in the elderly 2
  • Patients with a history of substance use: Both medications have some potential for misuse 4, 2
  • Patients taking other CNS depressants: Increased risk of sedation and cognitive impairment 4

Management Recommendations

Monitoring

When prescribing both medications concurrently:

  1. Monitor for pregabalin efficacy: Assess if pain control or other therapeutic effects of pregabalin are maintained

  2. Watch for adverse effects: Monitor for:

    • Changes in sleep patterns
    • Cognitive effects
    • Mood changes
    • Signs of toxicity
  3. Consider dose adjustments: Higher doses of pregabalin may be needed if modafinil reduces its effectiveness

Dosing Considerations

  • Start with standard doses of both medications
  • Consider timing of administration: Separate the doses by several hours if possible
  • Adjust pregabalin dose based on clinical response and adverse effects
  • Modify modafinil dose based on age and hepatic function 2

Special Considerations

Substance Abuse Risk

There is a potential for misuse with both medications:

  • Modafinil has some abuse potential, though lower than traditional stimulants 2, 3
  • Pregabalin has been associated with recreational use and dependency 5
  • The combination may be particularly concerning in patients with a history of substance use disorders

Alternative Options

If the interaction is problematic:

  1. For neuropathic pain: Consider duloxetine or gabapentin as alternatives to pregabalin 1, 4

  2. For excessive sleepiness: Consider lifestyle modifications or alternative wake-promoting agents

Conclusion

While there is no direct evidence of a severe interaction between modafinil and pregabalin, their concurrent use warrants careful monitoring due to modafinil's enzyme-inducing properties and the potential for additive CNS effects. Dose adjustments may be necessary, particularly for pregabalin, to maintain therapeutic efficacy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Chronic Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.